Biodexa Pharmaceuticals Statistics
Total Valuation
BDRX has a market cap or net worth of $178,542. The enterprise value is -$6.71 million.
Market Cap | 178,542 |
Enterprise Value | -6.71M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BDRX has 246,333 shares outstanding. The number of shares has increased by 8,714.17% in one year.
Shares Outstanding | 246,333 |
Shares Change (YoY) | +8,714.17% |
Shares Change (QoQ) | +1,802.61% |
Owned by Insiders (%) | 9.94% |
Owned by Institutions (%) | 18.94% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.37 |
Forward PS | n/a |
PB Ratio | 0.03 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.10.
Current Ratio | 1.26 |
Quick Ratio | 1.19 |
Debt / Equity | 0.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -181.56 |
Financial Efficiency
Return on equity (ROE) is -180.60% and return on invested capital (ROIC) is -155.85%.
Return on Equity (ROE) | -180.60% |
Return on Assets (ROA) | -88.10% |
Return on Capital (ROIC) | -155.85% |
Revenue Per Employee | $22,966 |
Profits Per Employee | -$426,703 |
Employee Count | 21 |
Asset Turnover | 0.05 |
Inventory Turnover | n/a |
Taxes
Income Tax | -507,544 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.28% in the last 52 weeks. The beta is 1.57, so BDRX's price volatility has been higher than the market average.
Beta (1Y) | 1.57 |
52-Week Price Change | -96.28% |
50-Day Moving Average | 1.16 |
200-Day Moving Average | 3.23 |
Relative Strength Index (RSI) | 35.42 |
Average Volume (30 Days) | 2,127,120 |
Short Selling Information
The latest short interest is 189,612, so 76.97% of the outstanding shares have been sold short.
Short Interest | 189,612 |
Short Previous Month | 66,761 |
Short % of Shares Out | 76.97% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, BDRX had revenue of $482,278 and -$8.96 million in losses. Loss per share was -$10.00.
Revenue | 482,278 |
Gross Profit | 476,292 |
Operating Income | -10.02M |
Pretax Income | -9.36M |
Net Income | -8.96M |
EBITDA | -8.96M |
EBIT | -9.31M |
Loss Per Share | -$10.00 |
Balance Sheet
The company has $7.46 million in cash and $580,051 in debt, giving a net cash position of $6.88 million or $27.95 per share.
Cash & Cash Equivalents | 7.46M |
Total Debt | 580,051 |
Net Cash | 6.88M |
Net Cash Per Share | $27.95 |
Equity / Book Value | 5.85M |
Book Value Per Share | 23.74 |
Working Capital | 1.83M |
Cash Flow
In the last 12 months, operating cash flow was -$9.59 million and capital expenditures -$27,502, giving a free cash flow of -$9.62 million.
Operating Cash Flow | -9.59M |
Capital Expenditures | -27,502 |
Free Cash Flow | -9.62M |
FCF Per Share | -$13.84 |
Margins
Gross margin is 98.76%, with operating and profit margins of -2,077.30% and -1,858.01%.
Gross Margin | 98.76% |
Operating Margin | -2,077.30% |
Pretax Margin | -1,940.18% |
Profit Margin | -1,858.01% |
EBITDA Margin | -1,856.98% |
EBIT Margin | -1,929.55% |
FCF Margin | -1,994.10% |
Dividends & Yields
BDRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8,714.17% |
Shareholder Yield | -8,714.17% |
Earnings Yield | -5,018.85% |
FCF Yield | -5,386.46% |
Analyst Forecast
The average price target for BDRX is $8.00, which is 1,011.11% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.00 |
Price Target Difference | 1,011.11% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 5, 2023. It was a reverse split with a ratio of 1:80.
Last Split Date | Jul 5, 2023 |
Split Type | Reverse |
Split Ratio | 1:80 |
Scores
BDRX has an Altman Z-Score of -21.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -21.34 |
Piotroski F-Score | 2 |